Recursion (NASDAQ: RXRX) is a clinical stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

A Note on Applying to Recursion: 

Please be aware that Recursion will never initiate contact with applicants via text message nor conduct interviews through messaging apps, freelance sites, or social media platforms. Our team will never ask for personal financial information or personal identification information, such as banking account numbers, social security, or driver’s license numbers, nor would we charge job seekers fees or request you to purchase anything as part of the recruitment process. The only legitimate business email domains we use are @recursion.com or @recursionpharma.com, and our team members will never use a Gmail or other personal email address to contact potential applicants.